10 research outputs found

    Finishing the euchromatic sequence of the human genome

    Get PDF
    The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

    Custom 4-Plex DiLeu Isobaric Labels Enable Relative Quantification of Urinary Proteins in Men with Lower Urinary Tract Symptoms (LUTS)

    No full text
    <div><p>The relative quantification of proteins using liquid chromatography mass spectrometry (LC-MS) has allowed researchers to compile lists of potential disease markers. These complex quantitative workflows often include isobaric labeling of enzymatically-produced peptides to analyze their relative abundances across multiple samples in a single LC-MS run. Recent efforts by our lab have provided scientists with cost-effective alternatives to expensive commercial labels. Although the quantitative performance of these dimethyl leucine (DiLeu) labels has been reported using known ratios of complex protein and peptide standards, their potential in large-scale proteomics studies using a clinically relevant system has never been investigated. Our work rectifies this oversight by implementing 4-plex DiLeu to quantify proteins in the urine of aging human males who suffer from lower urinary tract symptoms (LUTS). Protein abundances in 25 LUTS and 15 control patients were compared, revealing that of the 836 proteins quantified, 50 were found to be differentially expressed (>20% change) and statistically significant (p-value <0.05). Gene ontology (GO) analysis of the differentiated proteins showed that many were involved in inflammatory responses and implicated in fibrosis. While confirmation of individual protein abundance changes would be required to verify protein expression, this study represents the first report using the custom isobaric label, 4-plex DiLeu, to quantify protein abundances in a clinically relevant system.</p></div

    PSEA-Quant analysis of quantified protein set.

    No full text
    <p>PSEA-Quant analysis generated complementary GO processes when compared with DAVID. Protein numbers on the x-axis represent the complete set of proteins found in the dataset associated with a particular GO-term. Many processes and cellular component descriptions like cytoskeletal part, Z disc, intermediate filament organization, and cytoskeleton organization have been implicated in fibrosis. GO results suggested that fibrosis plays a key role in the onset and pathogenesis of LUTS.</p

    Volcano plot of quantified urinary proteins.

    No full text
    <p>The volcano plot of quantified urinary proteins reveals that 50 such proteins showed expression in LUTS patients compared to control samples. Proteins with fold-changes of 20% and p-values < 0.05 are shown in pink. Each protein was further characterized through literature searches and GO-term enrichment analysis.</p

    Fragmentation of DiLeu-labeled urinary peptides.

    No full text
    <p>Fragmentation of DiLeu-labeled urinary peptides yielded rich b- and y- product ion MS<sup>2</sup> spectra. Reporter ion intensities were compared across PSMs to determine if proteins were up- or down-regulated.</p

    Isotopic impurities in 4-plex DiLeu reagents.

    No full text
    <p>a) Isotopic impurities in 4-plex DiLeu reagents cause reporter ion signals at 1:1:1:1 ratios to be slightly lower and differ from one another (0.92:0.81:0.88:0.94) in intensity. Correction factors are applied to account for these differences. b) An MS<sup>2</sup> resolution of 17.5K allows elucidation of reporter ion impurities from signals while maintaining a rapid MS<sup>2</sup> acquisition speed.</p
    corecore